Skip to content

ARYSTA LIFESCIENCE BENELUX

Active
Private limited companyfounded 2005active for 20 yearsRue de Renory 26, 4102 Seraing, BelgiumKBO/BCE: BE 0877.444.281
Summary

ARYSTA LIFESCIENCE BENELUX has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €158.3m and a net result of €8.1m. Equity is growing by about 18% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Manufacture of chemicals and chemical products
NACE 20200Wholesale of industrial chemicals NACE 46851
2nd largest company by total assets in the province of Liège, Chemicals sector1 site
Size
€118.4mturnover 2025
Staff
38.2 FTE
Equity
€158.3m
Profit
€8.1m
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
UPL LIMITED
Holdings
1
Auditor: BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES2025 accounts on time
Why 88raises riskFigures for financial year 2025 (filed 06-11-2025)Liquidity: current ratio 4.72, cash €457,108lowers riskEquity €158.3m (82.0% of total assets)Size: turnover €118.4m, 38.2 FTE, total assets €193.1mShow the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 64% of its sector peers (NACE 20, small)
Financial strength · tick = 2023
Strong
Solvency 100+5
equity 82.0% of total assets
Liquidity 45+7
short-term debt 18.0% · cash 0.2%
Profitability 69-15
return on assets 4.2%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (147 companies, NACE 20, small)
Last 24 months 11-2024: 0.3% 12-2024: 0.4%▲ +0.1 percentage points vs 11-2024 01-2025: 0.7%▲ +0.3 percentage points vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.9%▲ +0.2 percentage points vs 02-2025 04-2025: 1.5%▲ +0.6 percentage points vs 03-2025 05-2025: 1.5%● unchanged vs 04-2025 06-2025: 1.5%● unchanged vs 05-2025 07-2025: 1.3%▼ -0.2 percentage points vs 06-2025 08-2025: 1.3%● unchanged vs 07-2025 09-2025: 1.3%● unchanged vs 08-2025 10-2025: 1.3%● unchanged vs 09-2025 11-2025: 1.6%▲ +0.3 percentage points vs 10-2025highest value 12-2025: 0.1%▼ -1.5 percentage points vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026lowest value 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.3%▲ +0.2 percentage points vs 09-2026
Credit of up to €11,800,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.72, compared with 2.79 in 2023, above the usual 1.5; short-term debt: 18% and cash: 0.2% of total assets), and 18% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 20, small): better than 91% on solvency, 49% on liquidity and 51% on profitability.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Figures for financial year 2025 (filed 06-11-2025)
NBB · annual accounts
raises risk · Liquidity: current ratio 4.72, cash €457,108
NBB · annual accounts
lowers risk · Equity €158.3m (82.0% of total assets)
NBB · annual accounts
lowers risk · Size: turnover €118.4m, 38.2 FTE, total assets €193.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 31-10-2025, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
6 days early
2023
1 day early
2022
13 days early
2021
2 days early
2020
72 days late
2018
71 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 20) for financial year 2024 is 22 days before the deadline, and 27% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-03-2026 is due by 31-10-2026. Nothing is late today. The company usually files around 29 October (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-03-2026 year end24-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Amendment of the articles · MiscellaneousCorrection
  2. Resignation: Alan PIROTTE (director)Director discharge
  3. Annual accounts filedfinancial year 2025 · unclassified…

Key points

  • Positive: 2nd largest company by total assets in the province of Liège, Chemicals…in the Checked rankings No. 2 View
  • Caution: A director leftlatest change 29-06-2026 · 1 in office 1 left View
  • Controlled by UPL LIMITEDthe company in turn controls 1 companies parent View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

By topic

Financials

Financial year
2025
Turnover
€118.4m
Profit
€8.1m
Solvency
82.0%
Turnover▼ 48.2%
Net result
20212025
Go to Financials

Board & ownership

Board
1 member
Parent
UPL LIMITED
Auditor
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
  • Guilhem De GaillardDirector
Go to Board & ownership

Timeline

Events
52
Since
2006
Next accounts
by 31-10-2026
  1. 21-10-2025Resignation: Jeroen Voorbraak (director)
  2. 31-03-2025Weakest financial year
  3. 06-02-2025Reappointment: BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES (statutory auditor)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Manufacture of chemicals and chemical productsNACE 20200
Founded
23-11-2005
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
2
Purpose
“La société a pour objet, tant en Belgique qu'en tout endroit de l'Union Européenne et…” (deed in French)
Go to Articles of association

Key facts about ARYSTA LIFESCIENCE BENELUX

What is the company number of ARYSTA LIFESCIENCE BENELUX?
0877.444.281. In Belgium the VAT number is the company number with BE in front: BE 0877.444.281.
Where is ARYSTA LIFESCIENCE BENELUX based?
The registered office is at Rue de Renory 26, 4102 Seraing.Company details
What does ARYSTA LIFESCIENCE BENELUX do?
According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20200).
What is the legal form of ARYSTA LIFESCIENCE BENELUX?
Private limited company (BV).
When was ARYSTA LIFESCIENCE BENELUX founded?
On 23-11-2005.
Is ARYSTA LIFESCIENCE BENELUX still active?
Yes, ARYSTA LIFESCIENCE BENELUX is an active enterprise in the KBO register.
How many employees does ARYSTA LIFESCIENCE BENELUX have?
On average 38.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of ARYSTA LIFESCIENCE BENELUX?
€118.4m in financial year 2025, according to the filed annual accounts.
Is ARYSTA LIFESCIENCE BENELUX profitable?
In financial year 2025, ARYSTA LIFESCIENCE BENELUX made a profit of €8.1m.
Where can I find the annual accounts of ARYSTA LIFESCIENCE BENELUX?
ARYSTA LIFESCIENCE BENELUX filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ARYSTA LIFESCIENCE BENELUX due?
By 31-10-2026, for financial year 2026.Timeline

Companies related to ARYSTA LIFESCIENCE BENELUX

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.